Nephrology Dialysis Transplantation,
Год журнала:
2023,
Номер
39(5), С. 752 - 760
Опубликована: Ноя. 15, 2023
ABSTRACT
Fibrotic
diseases
are
characterized
by
the
uncontrolled
accumulation
of
extracellular
matrix
(ECM)
components
leading
to
disruption
tissue
homeostasis.
Myofibroblasts
as
main
ECM-producing
cells
can
originate
from
various
differentiated
cell
types
after
injury.
Particularly,
process
endothelial-to-mesenchymal
transition
(endMT),
describing
phenotypic
shifts
endothelial
adopt
a
fully
mesenchymal
identity,
may
contribute
pool
myofibroblasts
in
fibrosis,
while
capillary
rarefaction
and
exacerbation
hypoxia.
In
renal
disease,
incomplete
recovery
acute
kidney
injury
(AKI)
ensuing
fibrotic
reaction
stand
out
major
contributors
chronic
disease
(CKD)
development.
While
focus
has
largely
been
on
impaired
tubular
epithelial
repair
potential
fibrosis-driving
mechanism,
alterations
microcirculation
post-AKI,
particular
endMT
maladaptive
response,
could
hold
equal
significance.
Dysfunctional
interplays
among
microenvironment
instigate
endMT.
Transforming
growth
factor
beta
(TGF-β)
signaling,
with
its
downstream
activation
canonical/Smad-mediated
non-canonical
pathways,
identified
primary
driver
this
process.
However,
non-TGF-β-mediated
pathways
involving
inflammatory
agents
metabolic
intercellular
communication
within
also
trigger
These
harmful,
cell–cell
interactions
signaling
offer
targets
for
therapeutic
intervention
impede
decelerate
fibrogenesis
such
AKI–CKD
progression.
Presently,
partial
reduction
TGF-β
using
anti-diabetic
drugs
or
statins
context.
Nevertheless,
further
investigation
is
warranted
validate
underlying
mechanisms
assess
positive
effects
clinical
framework.
Frontiers in Oncology,
Год журнала:
2024,
Номер
14
Опубликована: Авг. 26, 2024
To
date,
despite
extensive
research,
the
prognosis
of
advanced
osteosarcoma
has
not
improved
significantly.
Thus,
patients
experience
a
reduced
survival
rate,
suggesting
that
reevaluation
current
treatment
strategies
is
required.
Recently,
in
addition
to
routine
surgery,
chemotherapy
and
radiotherapy,
researchers
have
explored
more
effective
safer
treatments,
including
targeted
therapy,
immunotherapy,
anti-angiogenesis
metabolic
targets
nanomedicine
therapy.
The
tumorigenesis
development
closely
related
angiogenesis.
therapy
crucial
treat
osteosarcoma;
however,
recent
clinical
trials
found
it
insufficient
efficacy.
solve
this
problem,
causes
failure
improve
should
be
investigated.
This
review
focuses
on
summarizing
pathophysiological
mechanisms
angiogenesis
advances
osteosarcoma.
We
also
discuss
some
studies,
with
aim
providing
new
ideas
for
patients.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 12, 2025
Abstract
Pulmonary
hypertension
(PH)
increases
the
mortality
of
preterm
infants
with
bronchopulmonary
dysplasia
(BPD).
There
are
no
curative
therapies
for
this
disease.
Lung
endothelial
carnitine
palmitoyltransferase
1a
(Cpt1a),
rate‐limiting
enzyme
shuttle
system,
is
reduced
in
a
rodent
model
BPD.
It
unknown
whether
Cpt1a
reduction
causes
pulmonary
vascular
(PV)
remodeling.
The
latter
can
be
result
endothelial‐mesenchymal
transition
(EndoMT).
Here,
cell
(EC)‐specific
KO
and
WT
mice
(<12
h
old)
exposed
to
hyperoxia
(70%
O
2
)
14
days
allow
them
recover
normoxia
until
postnatal
day
28.
Hyperoxia
PH,
which
aggravated
EC‐specific
mice.
Upregulating
expression
inhibits
hyperoxia‐induced
PV
lung
EndoMT,
detected
by
immunofluorescence,
scRNA‐sequencing,
EC
lineage
tracing,
further
increased
Blocking
EndoMT
Male
under
same
high
oxygen
conditions
develop
higher
degree
PH
than
females,
associated
expression.
Conclusively,
neonatal
decreasing
upregulating
EndoMT.
This
provides
valuable
strategy
developing
targeted
levels
or
inhibiting
treat
BPD‐associated
PH.
The
tumor
microenvironment
(TME)
of
non-small
cell
lung
cancer
(NSCLC)
is
highly
heterogeneous
and
involved
in
tumorigenesis
resistance
to
therapy.
Among
the
cells
TME,
endothelial
are
associated
with
latter
processes
through
endothelial-to-mesenchymal
transition
(EndMT).
During
EndMT,
(ECs)
progressively
lose
their
phenotype
favor
a
mesenchymal
phenotype,
which
favors
production
cancer-associated
fibroblasts
(CAFs).
Our
study
aimed
investigate
consequences
exposure
different
secretomes
on
EC
plasticity.
Conditioned
media
(CM)
were
prepared
from
lines
A549,
H1755,
H23,
H1437,
H1975.
Proliferation
migration
ECs
treated
these
CMs
assessed
by
Cyquant
Incucyte
technologies,
respectively.
angiogenic
capacity
was
following
tubulogenesis
Matrigel.
Phenotypic
changes
detected
flow
cytometry.
Morphological
analysis
actin
fibers
performed
immunohistochemistry,
while
proteomic
mass
spectrometry
used
identify
protein
content
secretomes.
A
change
found
when
human
umbilical
vein
(HUVECs)
CMs.
This
phenotypic
morphological
change,
an
increase
both
stress
fiber
expression
spontaneous
migration.
Furthermore,
markers
(α-SMA
CD44)
confirmed
changes.
However,
did
not
modify
rate
double-labeled
(vWF+/α-SMA+
or
CD31+/CD44+).
Proteomic
identified
potential
targets
EndMT
therapeutic
relevance.
Taken
together,
data
suggest
that
can
induce
partial
EndMT.
Cells,
Год журнала:
2025,
Номер
14(5), С. 378 - 378
Опубликована: Март 5, 2025
Endothelial
dysfunction
is
the
main
initiating
factor
in
atherosclerosis.
Through
mechanotransduction,
shear
stress
regulates
endothelial
cell
function
both
homeostatic
and
diseased
states.
Accumulating
evidence
reveals
that
epigenetic
changes
play
critical
roles
etiology
of
cardiovascular
diseases,
including
The
metabolic
regulation
epigenetics
has
emerged
as
an
important
control
gene
expression
states,
but
to
best
our
knowledge,
this
connection
remains
largely
unexplored
In
review,
we
(1)
summarize
how
(or
flow)
(dys)function;
(2)
explore
alterations
occur
endothelium
response
disturbed
flow;
(3)
review
metabolism
under
different
conditions;
(4)
suggest
mechanisms
which
may
link
altered
epigenome
by
modulations
metabolite
availability.
We
believe
plays
role
reprogramming
could
pave
way
for
novel
metabolism-based
therapeutic
strategies.
Cancer
and
cardiovascular
disease
remain
the
leading
causes
of
morbidity
mortality
worldwide,
two
separate
entities
share
several
similarities
possible
interactions.
Patients
with
cancer
may
have
underlying
disease,
which
is
often
exacerbated
by
stress
tumor
growth
or
treatment.
At
same
time,
cardiotoxicity
induced
anti-cancer
therapies
malignant
process
itself
can
lead
to
new
diseases.
Efforts
been
made
find
a
rational
explanation
for
this
phenomenon.
As
classical
tumor-promoting
factor,
we
notice
that
SNAI2
simultaneously
plays
an
important
pathogenic
role
in
Moreover,
there
are
striking
parallels
mechanisms
CVD,
such
as
shared
risk
factors
(e.g.,
smoking
diabetes),
cellular
phenotypic
switching,
metabolic
remodeling,
all
mediated
SNAI2.
This
review
aims
summarize
SNAI2's
core
linking
well
explore
therapeutic
approaches
targeting
also
seeks
provide
insights
into
common
both
CVD.
Cellular and Molecular Life Sciences,
Год журнала:
2025,
Номер
82(1)
Опубликована: Апрель 17, 2025
Brain
injury
is
a
common
sequela
following
cardiac
arrest
(CA),
with
up
to
70%
of
hospitalized
patients
dying
from
it.
microvascular
endothelial
cells
(BMVECs)
play
crucial
role
in
post-cardiac
brain
(PCABI).
However,
the
effects
and
mechanisms
targeting
BMVEC
energy
metabolism
mitigate
remain
unclear.
We
established
mouse
model
by
injecting
potassium
chloride
into
right
internal
jugular
vein.
Mass
spectrometry
detected
targeted
changes
short-chain
fatty
acids
metabolites
CA/CPR
group
compared
sham
group.
Mice
overexpressed
ACSS2
BMVECs
were
created
using
an
AAV-BR1
vector,
knockout
mice
generated
CRE-LOXP
system.
The
oxygen
glucose
deprivation/re-oxygenation
(OGD/R)
was
investigate
vitro.
Metabolomics
analysis
revealed
disrupted
cerebral
post-CA/CPR,
decreased
acetyl-CoA
amino
acids.
Overexpression
increased
levels
improved
neurological
function.
Vascular
cell-specific
exhibited
reduced
aortic
sprouting
dysfunction
influenced
autophagy
interacting
transcription
factor
EB
(TFEB)
modulating
AMP-activated
protein
kinase
α
(AMPKα)
pathway.
Our
study
shows
that
modulates
biological
functions
promoting
autophagy.
Enhancing
via
may
target
PCABI
treatment
development.